How have AFIB shares performed in 2024?

Acutus Medical's stock was trading at $0.2019 on January 1st, 2024. Since then, AFIB shares have decreased by 14.8% and is now trading at $0.1721. View the best growth stocks for 2024 here .

Are investors shorting Acutus Medical?

Acutus Medical saw a drop in short interest in March. As of March 31st, there was short interest totaling 845,200 shares, a drop of 14.2% from the March 15th total of 984,700 shares. Based on an average daily trading volume, of 2,250,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 4.5% of the shares of the stock are short sold. View Acutus Medical's Short Interest .

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our AFIB earnings forecast .

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) announced its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The firm had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 166.79% and a negative trailing twelve-month return on equity of 35.31%. During the same period in the previous year, the firm earned ($1.18) EPS.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH) , Alibaba Group (BABA) , Checkmate Pharmaceuticals (CMPI) , Salesforce (CRM) , Walt Disney (DIS) , DocuSign (DOCU) , Marvell Technology (MRVL) , NVIDIA (NVDA) , Tesla (TSLA) and Twilio (TWLO) .

When did Acutus Medical IPO?

Acutus Medical (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Acutus Medical have any subsidiaries?

The following companies are subsidiares of Acutus Medical: Acutus Medical N.V.. Read More

NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free AFIB Stock Alerts

$0.17

+0.01 (+6.17%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.16
▼
$0.19
50-Day Range: $0.16
▼
$0.26
52-Week Range: $0.16
▼
$1.09

Volume: 729,302 shs
Average Volume: 1.98 million shs
Market Capitalization: $5.11 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Acutus Medical alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Acutus Medical Stock (NASDAQ:AFIB)

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.

AFIB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AFIB Stock News Headlines

April 18, 2024 | msn.com

University of Iowa Health Care marks 500th atrial fibrillation treatment procedure

April 18, 2024 | msn.com

Study reveals long-term consequences of atrial fibrillation

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 18, 2024 | msn.com

Study: Heart failure, not stroke, most common complication of atrial fibrillation

April 16, 2024 | msn.com

New procedure to treat atrial fibrillation offered at Baptist Health Paducah

April 15, 2024 | msn.com

Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events

April 15, 2024 | msn.com

Grand Rapids hospital first in Midwest to use new procedure to treat AFib

April 14, 2024 | americanbankingnews.com

Short Interest in Acutus Medical, Inc. (NASDAQ:AFIB) Decreases By 14.2%

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 12, 2024 | msn.com

Local doctor discusses new treatment option for AFib

April 12, 2024 | msn.com

Periodontitis May Modify Risk for Atrial Fibrillation

April 12, 2024 | msn.com

Treating gum disease during AFib blanking period could reduce recurrence risk

April 10, 2024 | msn.com

Treating gum disease after heart rhythm ablation reduces risk of AFib recurrence, study finds

April 9, 2024 | msn.com

Experts give recommendations for longer and better lives for patients with atrial fibrillation

April 9, 2024 | msn.com

Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

April 8, 2024 | msn.com

YOUR HEALTH: Pioneering safe Afib surgery

April 8, 2024 | msn.com

International experts agree on standards for catheter ablation of atrial fibrillation

April 4, 2024 | finanznachrichten.de

Catheter Precision, Inc. Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year

April 3, 2024 | finance.yahoo.com

Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022)

April 2, 2024 | msn.com

New tech uses high energy to help treat a-fib

April 1, 2024 | globenewswire.com

Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results

March 30, 2024 | msn.com

New research advocates genetic screening in early onset atrial fibrillation

March 28, 2024 | msn.com

Medical Moment: AI getting hearts in rhythm

March 28, 2024 | msn.com

Genetic testing of patients with atrial fibrillation can alert clinicians to potential life-threatening conditions

March 28, 2024 | msn.com

'Much safer for patients': Nebraska Medicine rolls out new heart procedure for AFib

March 25, 2024 | msn.com

Diet and Sugary Drinks Linked to Higher Atrial Fibrillation Risk, Study Shows

March 22, 2024 | msn.com

Blood tests could identify people with AFib at risk for 'breakthrough' stroke

See More Headlines

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:AFIB
CUSIP: N/A
CIK: 1522860
Web: www.acutusmedical.com
Phone: 442-232-6080
Fax: 442-232-6081
Employees: 230
Year Founded: 2011

Profitability

EPS (Most Recent Fiscal Year): ($1.24)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-81,660,000.00
Net Margins: -166.79%
Pretax Margin: -165.52%
Return on Equity: -35.31%
Return on Assets: -13.43%

Debt

Debt-to-Equity Ratio: 1.10
Current Ratio: 2.44
Quick Ratio: 2.22

Sales & Book Value

Annual Sales: $7.16 million
Price / Sales: 0.68
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.03) per share
Price / Book: -5.46

Miscellaneous

Outstanding Shares: 29,720,000
Free Float: 28,676,000
Market Cap: $4.87 million
Optionable: Optionable
Beta: 0.19

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Takeo Mukai (Age 43)
CEO & CFO
Mr. Gary W. Doherty (Age 58)
Senior Vice President of Finance
Comp: $434.32k

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AFIB Stock Analysis - Frequently Asked Questions

How have AFIB shares performed in 2024?: Acutus Medical's stock was trading at $0.2019 on January 1st, 2024. Since then, AFIB shares have decreased by 14.8% and is now trading at $0.1721.
View the best growth stocks for 2024 here.
Are investors shorting Acutus Medical?: Acutus Medical saw a drop in short interest in March. As of March 31st, there was short interest totaling 845,200 shares, a drop of 14.2% from the March 15th total of 984,700 shares. Based on an average daily trading volume, of 2,250,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 4.5% of the shares of the stock are short sold.
View Acutus Medical's Short Interest.
When is Acutus Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AFIB earnings forecast.
How were Acutus Medical's earnings last quarter?: Acutus Medical, Inc. (NASDAQ:AFIB) announced its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The firm had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 166.79% and a negative trailing twelve-month return on equity of 35.31%. During the same period in the previous year, the firm earned ($1.18) EPS.

What other stocks do shareholders of Acutus Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).
When did Acutus Medical IPO?: Acutus Medical (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
How do I buy shares of Acutus Medical?: Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Acutus Medical have any subsidiaries?: The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More

This page (NASDAQ:AFIB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Acutus Medical (AFIB) Stock Price, News & Analysis

About Acutus Medical Stock (NASDAQ:AFIB)

AFIB Stock Price History

AFIB Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

AFIB Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info